Use of Recurrence Score Combined With Clinical, Genetic Factors Improves Prognostic Ability in HR+/ HER2– Early Breast Cancer

There is a prognostic impact of clinical and immunohistochemistry markers.

Related Keywords

San Antonio ,Texas ,United States ,Rick Baehner ,National Surgical Adjuvant Breast ,European Society For Medical Oncology Congress ,European Society ,Medical Oncology Congress ,Bowel Project ,San Antonio Breast Cancer ,